Kalina Kawecka-Jaszcz Selected Research

Quinapril (Accupril)

6/2017	The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases.
2/2007	Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial.
6/2003	Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kalina Kawecka-Jaszcz Research Topics

Disease

48	Hypertension (High Blood Pressure) 08/2018 - 01/2002
17	Myocardial Infarction 01/2015 - 01/2002
11	Coronary Artery Disease (Coronary Atherosclerosis) 08/2018 - 01/2002
10	Heart Failure 01/2014 - 01/2002
9	Stroke (Strokes) 01/2021 - 05/2007
9	Heart Diseases (Heart Disease) 01/2013 - 01/2003
8	Acute Coronary Syndrome 01/2021 - 11/2002
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2003
7	Essential Hypertension 09/2010 - 01/2004
5	Inflammation (Inflammations) 01/2013 - 08/2006
5	Myocardial Ischemia (Ischemic Heart Diseases) 01/2007 - 01/2003
4	Hypercholesterolemia 06/2016 - 09/2003
4	Atherosclerosis 06/2016 - 01/2007
4	Diabetes Mellitus 01/2013 - 03/2003
4	Neoplasms (Cancer) 01/2012 - 02/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2005
3	Atrial Fibrillation 05/2019 - 01/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2007
3	Hemorrhage 08/2009 - 03/2004
3	Infarction (Infarctions) 01/2007 - 09/2004
3	Unstable Angina 01/2005 - 09/2003
2	Overweight 01/2021 - 01/2015
2	Left Ventricular Dysfunction 01/2017 - 01/2004
2	Obesity 01/2014 - 01/2004
2	Cardiotoxicity 02/2013 - 01/2012
2	Stable Angina 07/2012 - 01/2011
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 09/2010 - 08/2006
2	Chronic Kidney Failure (Chronic Renal Failure) 03/2010 - 08/2006
2	Heart Arrest (Cardiac Arrest) 04/2008 - 05/2007
2	Glucose Intolerance 01/2007 - 01/2007
2	Insulin Resistance 01/2007 - 01/2002
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2005 - 06/2002
1	Weight Gain 01/2017
1	Mood Disorders (Mood Disorder) 01/2016
1	Orthostatic Hypotension (Postural Hypotension) 01/2016
1	Masked Hypertension 05/2013
1	ST Elevation Myocardial Infarction 01/2013
1	Vascular Diseases (Vascular Disease) 07/2012

Drug/Important Bio-Agent (IBA)

12	Antihypertensive Agents (Antihypertensives)IBA 01/2016 - 01/2003
7	SodiumIBA 04/2013 - 02/2004
6	LDL CholesterolIBA 08/2018 - 09/2003
6	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 01/2007
6	LipidsIBA 07/2010 - 01/2002
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2016 - 11/2002
4	SaltsIBA 04/2013 - 08/2004
4	adducinIBA 01/2011 - 08/2003
3	Quinapril (Accupril)FDA LinkGeneric 06/2017 - 06/2003
3	Amlodipine (Norvasc)FDA LinkGeneric 06/2017 - 06/2003
3	Pharmaceutical PreparationsIBA 02/2013 - 09/2003
3	C-Reactive ProteinIBA 01/2011 - 08/2006
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2004 - 02/2004
3	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 12/2004 - 02/2004
2	Losartan (Cozaar)FDA LinkGeneric 06/2017 - 06/2003
2	PotassiumIBA 04/2013 - 10/2005
2	Ouabain (G Strophanthin)IBA 01/2011 - 10/2005
2	Adenosine Triphosphatases (ATPase)IBA 01/2011 - 10/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2011 - 08/2006
2	AldosteroneIBA 01/2011 - 12/2004
2	LeptinIBA 07/2010 - 03/2009
2	AngiotensinogenIBA 01/2010 - 10/2004
2	ElementsIBA 01/2010 - 01/2004
2	CalciumIBA 01/2010 - 01/2007
2	Fibrinogen (Factor I)FDA Link 03/2009 - 08/2006
2	Dihydrotachysterol (AT 10)IBA 01/2007 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 01/2006
2	HomocysteineIBA 01/2005 - 01/2003
2	Angiotensin IIIBA 12/2004 - 10/2004
1	lipoprotein cholesterolIBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Bisoprolol (Concor)FDA LinkGeneric 06/2017
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Xanthine OxidaseIBA 11/2016
1	Uric Acid (Urate)IBA 11/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2016
1	Sex Hormone-Binding GlobulinIBA 06/2016
1	Testosterone (Sustanon)FDA Link 06/2016
1	hydroxide ionIBA 01/2016
1	Mineralocorticoid Receptor AntagonistsIBA 01/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2013
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	Adenosine A1 ReceptorIBA 07/2012
1	capadenosonIBA 07/2012
1	FibrinIBA 07/2012

Therapy/Procedure

14	Therapeutics 01/2014 - 06/2002
13	Secondary Prevention 08/2018 - 01/2003
7	Myocardial Revascularization 01/2021 - 01/2004
6	Drug Therapy (Chemotherapy) 01/2014 - 01/2004
6	Percutaneous Coronary Intervention 01/2011 - 09/2003
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2011 - 09/2003
4	Cardiac Rehabilitation 06/2016 - 01/2002
4	Cardiac Resynchronization Therapy 05/2012 - 01/2009
2	Defibrillators (Defibrillator) 01/2014 - 08/2005
2	Heart Transplantation (Grafting, Heart) 04/2008 - 05/2007
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2004 - 01/2002
1	Denervation 05/2019
1	Spinal Cord Stimulation 01/2014